Caricamento...
Oligoclonal Antibodies to Target the ErbB Family
INTRODUCTION: Use of monoclonal antibodies to inhibit signaling through the ErbB receptor tyrosine kinase family has proven to be an effective strategy for treating ErbB-driven cancers. Advances in the field of antibody engineering and manufacturing now allow us to more effectively mimic the natural...
Salvato in:
| Pubblicato in: | Expert Opin Biol Ther |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2015
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4480362/ https://ncbi.nlm.nih.gov/pubmed/25936923 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/14712598.2015.1042362 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|